A randomised controlled trial comparing Phospo-Soda Buffered Saline (Fleet ®) with Sodium Picosulphate/Magnesium Citrate (Picoprep ®) in the preparation of patients for colonoscopy".
A Randomised Controlled Trial (RCT) comparing the efficacy and acceptability of Phospo-Soda Buffered Saline (Fleet ®) with Sodium Picosulphate/Magnesium Citrate (Picoprep ®) in the preparation of patients for colonoscopy.
Frank Frizelle
73 participants
Jan 1, 2004
Interventional
Conditions
Summary
The adequacy and efficacy of various small-volume bowel preparations for colonoscopy has become increasingly popular due to improved tolerance by patients and equivalent efficacy compared with the larger volume preparations. Comparative studies however between small volume preparations are lacking. This randomised controlled trial aims to compare the efficacy and acceptability of phospo-soda buffered saline (Fleet ®) with sodium picosulphate/ magnesium citrate (Picoprep ®) in the preparation of patients for colonoscopy.
Eligibility
Inclusion Criteria1
- All patients (male and female, over 16 years , no maximum age limit) coming forward for colonoscopy who were fit for procedure.
Exclusion Criteria1
- Pregnant, suspected or known obstructing lesion.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
A randomised prospective trial designed to compare the efficacy and acceptability of phospo-soda buffered saline (Fleet ®)(control) with sodium picosulphate/ magnesium citrate (Picoprep ®) (intervention) in patients undergoing colonoscopy.The prepartion All patients also received 3 Bisacodyl tablets (Dulcolax, Boehringer Ingelheim, Germany) 2 days before the procedure (one day before phospo-soda buffered saline (Fleet) or sodium picosulphate/ magnesium citrate (picoprep)). Patients were encouraged to drink freely of clear fluids while taking the preparation in line with the manufacturer’s instructions, while obstaining from solid food for 24 hours prior to colonoscopy
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12607000337471